Skip to Main Content

Browse issues

Open Forum Infectious Diseases Cover Image for Volume 6, Issue 4
Volume 6, Issue 4
April 2019
EISSN 2328-8957

Volume 6, Issue 4, April 2019

Major Articles

Houda Ben Ayed and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz103, https://doi.org/10.1093/ofid/ofz103
Mica Blauw and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz111, https://doi.org/10.1093/ofid/ofz111
Emma E Ilett and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz086, https://doi.org/10.1093/ofid/ofz086
Jessica R Webb and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz091, https://doi.org/10.1093/ofid/ofz091
Dina F Khamash and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz062, https://doi.org/10.1093/ofid/ofz062
H Nina Kim and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz100, https://doi.org/10.1093/ofid/ofz100
Matthew A Spinelli and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz101, https://doi.org/10.1093/ofid/ofz101

Preexposure prophylaxis (PrEP) users in primary care continued PrEP for a median of 8 months. Transgender women experienced higher risk of early discontinuation; younger users experienced late discontinuation. Missed visits during PrEP are associated with discontinuation and should trigger outreach.

P Alexander Leahey and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz089, https://doi.org/10.1093/ofid/ofz089
Prateek Sehgal and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz081, https://doi.org/10.1093/ofid/ofz081

This population-wide cohort study highlights the phenomenon of unexpected deaths due to infectious disease, with respect to the key pathogens involved, the most prominent clinical syndromes, characteristics of those who died, and opportunities and challenges for prevention.

Shahileen Remtulla and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz098, https://doi.org/10.1093/ofid/ofz098

The impact of unsolicited antimicrobial stewardship initiated prospective audit and feedback using a standardized Staphylococcus aureus bacteremia management bundle was evaluated. Adherence to evidence-based recommendations was significantly improved with this simple yet effective intervention.

Diego R Falci and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz073, https://doi.org/10.1093/ofid/ofz073
Sharon Valenti and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz093, https://doi.org/10.1093/ofid/ofz093
Anita K Kambhampati and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz115, https://doi.org/10.1093/ofid/ofz115
Eun Hye Lee and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz118, https://doi.org/10.1093/ofid/ofz118
Daniela Francisci and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz112, https://doi.org/10.1093/ofid/ofz112
Evan J Zasowski and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz079, https://doi.org/10.1093/ofid/ofz079
Sharon E Frey and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz107, https://doi.org/10.1093/ofid/ofz107
Sébastien D Pion and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz019, https://doi.org/10.1093/ofid/ofz019
Sarah E Sansom and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz099, https://doi.org/10.1093/ofid/ofz099

With both liver biopsy (LB) and transient elastography (TE) with controlled attenuation parameter (CAP), advanced fibrosis was more associated with moderate-severe steatosis in patients with hepatitis C virus (HCV) monoinfection than in those with human immunodeficiency virus (HIV)/HCV coinfection. In patients with chronic hepatitis C undergoing liver fibrosis staging, steatosis was detected more often with CAP than with LB, with median CAP scores higher in HCV monoinfection than in HIV/HCV coinfection. A histopathologic finding of steatosis was not reported in >25% of LBs in this clinical setting. The severity of steatosis may be increasing in the modern HCV treatment era.

Derrick Nhan and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz104, https://doi.org/10.1093/ofid/ofz104
Bruce M Jones and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz109, https://doi.org/10.1093/ofid/ofz109
Megan B Cole and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz124, https://doi.org/10.1093/ofid/ofz124
Zerelda Esquer Garrigos and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz084, https://doi.org/10.1093/ofid/ofz084
Alaina S Ritter and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz057, https://doi.org/10.1093/ofid/ofz057
Rulan Griesel and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz094, https://doi.org/10.1093/ofid/ofz094
Anna P Ralph and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz097, https://doi.org/10.1093/ofid/ofz097
Johnny Gutierrez and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz090, https://doi.org/10.1093/ofid/ofz090
Katie E Barber and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz121, https://doi.org/10.1093/ofid/ofz121
Brittany L Kmush and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz144, https://doi.org/10.1093/ofid/ofz144
Ken F Blount and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz095, https://doi.org/10.1093/ofid/ofz095

In this randomized, double-blinded, placebo-controlled phase 2B trial, prevention of recurrent Clostridioides difficile infection with RBX2660 was associated with restorative microbiome changes implicated in resisting C. difficile colonization and recurrence. RBX2660 is more effective than placebo at restoring participant microbiomes.

Munjit Na Songkhla and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz132, https://doi.org/10.1093/ofid/ofz132
Riley H Hazard and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz140, https://doi.org/10.1093/ofid/ofz140

In hospitalized HIV-infected patients in Uganda, empiric antituberculosis therapy was associated with improved survival among patients with severe sepsis.

Nomonde R Mvelase and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz065, https://doi.org/10.1093/ofid/ofz065
Dimitrios P Kontoyiannis and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz138, https://doi.org/10.1093/ofid/ofz138
Verner N Orish and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz153, https://doi.org/10.1093/ofid/ofz153
Rishi Chanderraj and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz139, https://doi.org/10.1093/ofid/ofz139

Decreasing proton pump inhibitor use and preventing inappropriate antibiotic initiation are modifiable targets to decrease in-hospital vancomycin-resistant Enterococcus (VRE) transmission. Colonization pressures from patients identified as carriers and placed in contact precautions does not increase the odds of VRE acquisition.

Sanjeev Singh and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofy290, https://doi.org/10.1093/ofid/ofy290
Grace Roberts and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz072, https://doi.org/10.1093/ofid/ofz072
Takanori Asakura and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz108, https://doi.org/10.1093/ofid/ofz108

Our results demonstrate that sitafloxacin (STFX) may be effective in one-fourth of patients with refractory Mycobacterium avium complex lung disease. Surgery, low minimum inhibitory concentration of STFX, and clarithromycin resistance were predictors of negative sputum culture conversion.

Martina L Badell and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz129, https://doi.org/10.1093/ofid/ofz129
James C King and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz137, https://doi.org/10.1093/ofid/ofz137
Alessander O Guimaraes and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz126, https://doi.org/10.1093/ofid/ofz126
Antoni Torres and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz149, https://doi.org/10.1093/ofid/ofz149
Raina Aggarwal and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz146, https://doi.org/10.1093/ofid/ofz146
Stephen D Clark and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz162, https://doi.org/10.1093/ofid/ofz162
Margaux Chauvet and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz156, https://doi.org/10.1093/ofid/ofz156
Judith A Hahn and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz125, https://doi.org/10.1093/ofid/ofz125
Antoine Chaillon and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz160, https://doi.org/10.1093/ofid/ofz160
Melanie Frank and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz152, https://doi.org/10.1093/ofid/ofz152

In the country of Georgia, long-term outcomes among patients with extensively drug-resistant tuberculosis reveal significant rates of loss to follow-up and a high posttreatment mortality rate.

Sanjay Poudel and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz159, https://doi.org/10.1093/ofid/ofz159
Emma Sophia Kay and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz120, https://doi.org/10.1093/ofid/ofz120

Missed visits within the first 12 months after antiretroviral therapy initiation are a major risk factor for subsequent death in persons living with human immunodeficiency virus. Incorporating missed visits in clinical and public health retention and viral suppression programming is advised.

Soo-Yon Rhee and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz135, https://doi.org/10.1093/ofid/ofz135
Robert Ndege and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz154, https://doi.org/10.1093/ofid/ofz154
Porkaew Petchkum and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz155, https://doi.org/10.1093/ofid/ofz155
Erica J Weinstein and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz164, https://doi.org/10.1093/ofid/ofz164

Bacterial resistance continues to increase in the community. We found that community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacterales (formerly Enterobacteriaceae) could be predicted with knowledge of 5 clinical factors.

Anuradha Madan and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz163, https://doi.org/10.1093/ofid/ofz163

In this phase 2b, randomized, placebo-controlled study of intravenous danirixin in hospitalized influenza patients, all participants achieved a clinical response; danirixin had an acceptable safety profile. Early termination due to low recruitment and small sample size limits interpretation.

Marita Zimmermann and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz150, https://doi.org/10.1093/ofid/ofz150
Kathleen M Ward and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz166, https://doi.org/10.1093/ofid/ofz166

Highly efficacious therapies are necessary but not sufficient to eliminate HCV infection in persons with HIV infection. We evaluated the impact of peer-mentors and cash incentives on linkage to HCV treatment and cure in persons with HIV-HCV coinfection who had not been previously treated.

Elizabeth Wenqian Wang and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz116, https://doi.org/10.1093/ofid/ofz116

Since implementing use of the gastrointestinal multiplex panel (GIMP), we observed an increase in Yersinia enterocolitica infections, possibly related to the increase in patients with cancer receiving intensive immunosuppression, increased testing due to availability, and increased GIMP sensitivity.

Sabbir Haider and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz117, https://doi.org/10.1093/ofid/ofz117

Review Articles

Ingabire G Balinda and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz102, https://doi.org/10.1093/ofid/ofz102
Michael B Edmond
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofy214, https://doi.org/10.1093/ofid/ofy214

Mandatory influenza vaccination of healthcare workers is not supported by evidence. Efforts at reducing presenteeism are likely to be more effective than mandatory vaccination.

Trish M Perl and Thomas R Talbot
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz096, https://doi.org/10.1093/ofid/ofz096
Ivayla I Geneva and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz032, https://doi.org/10.1093/ofid/ofz032
Daniel B Chastain and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz133, https://doi.org/10.1093/ofid/ofz133

Brief Reports

F Ceia and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz063, https://doi.org/10.1093/ofid/ofz063
Sameer S Kadri and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz110, https://doi.org/10.1093/ofid/ofz110
Matthew P Cheng and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz114, https://doi.org/10.1093/ofid/ofz114
Alisa W Serio and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz123, https://doi.org/10.1093/ofid/ofz123
Julie Toubiana and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz122, https://doi.org/10.1093/ofid/ofz122
Parham Sendi and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz130, https://doi.org/10.1093/ofid/ofz130
Jennifer S Mulliken and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz134, https://doi.org/10.1093/ofid/ofz134
Giulio DiDiodato and Nellie Bradbury
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz119, https://doi.org/10.1093/ofid/ofz119
Jason Halperin and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz161, https://doi.org/10.1093/ofid/ofz161
Michael L Washburn and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz106, https://doi.org/10.1093/ofid/ofz106
Priya Nori and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz092, https://doi.org/10.1093/ofid/ofz092
Adrienne H Ma and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz141, https://doi.org/10.1093/ofid/ofz141
Bin Wu and Yuhao Wu
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz145, https://doi.org/10.1093/ofid/ofz145

ID Case

Arpita Chakravarti and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz088, https://doi.org/10.1093/ofid/ofz088
Iacopo Franconi and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz105, https://doi.org/10.1093/ofid/ofz105
Arvind Yerramilli and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz131, https://doi.org/10.1093/ofid/ofz131
Przemysław Kołodziej and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz157, https://doi.org/10.1093/ofid/ofz157

Correspondence

Noam Ship and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz127, https://doi.org/10.1093/ofid/ofz127

Corrigendum

Nang Thu Thu Kyaw and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz143, https://doi.org/10.1093/ofid/ofz143
Adam Abdullahi and others
Open Forum Infectious Diseases, Volume 6, Issue 4, April 2019, ofz142, https://doi.org/10.1093/ofid/ofz142
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close